These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36439184)

  • 1. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tartrolon D induces immunogenic cell death in melanoma.
    Brito TL; Edson EA; Dias Florêncio KG; Machado-Neto JA; Garnique ADMB; Mesquita Luiz JP; Cunha FQ; Alves-Filho JC; Haygood M; Wilke DV
    Chem Biol Interact; 2024 Sep; 400():111177. PubMed ID: 39097071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
    Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
    BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
    He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics.
    Ramon J; Engelen Y; De Keersmaecker H; Goemaere I; Punj D; Mejía Morales J; Bonte C; Berx G; Hoste E; Stremersch S; Lentacker I; De Smedt SC; Raemdonck K; Braeckmans K
    J Control Release; 2024 Jan; 365():1019-1036. PubMed ID: 38065413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy with doxorubicin and caffeine combination enhanced ICD induction and T-cell infiltration in B16F10 melanoma tumors.
    Yerragopu AK; Vellapandian C
    J Biochem Mol Toxicol; 2023 May; 37(5):e23327. PubMed ID: 36807623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.
    Hufnagel S; Xu H; Colemam MF; Valdes SA; Liu KA; Hursting SD; Cui Z
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):59-69. PubMed ID: 34698902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.
    Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y
    Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
    Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X
    ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity.
    Naessens F; Demuynck R; Vershinina O; Efimova I; Saviuk M; De Smet G; Mishchenko TA; Vedunova MV; Krysko O; Catanzaro E; Krysko DV
    Front Immunol; 2024; 15():1396349. PubMed ID: 39011040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
    ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of eIF2alpha phosphorylation during immunogenic cell death.
    Bezu L; Wu Chuang A; Humeau J; Kroemer G; Kepp O
    Methods Enzymol; 2019; 629():53-69. PubMed ID: 31727256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
    Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.
    Cullen JK; Yap PY; Ferguson B; Bruce ZC; Koyama M; Handoko H; Hendrawan K; Simmons JL; Brooks KM; Johns J; Wilson ES; de Souza MMA; Broit N; Stewart P; Shelley D; McMahon T; Ogbourne SM; Nguyen TH; Lim YC; Pagani A; Appendino G; Gordon VA; Reddell PW; Boyle GM; Parsons PG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
    Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells.
    Jafari S; Ardakan AK; Aghdam EM; Mesbahi A; Montazersaheb S; Molavi O
    Sci Rep; 2024 Oct; 14(1):23231. PubMed ID: 39369019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies.
    Mishchenko TA; Balalaeva IV; Turubanova VD; Saviuk MO; Shilyagina NY; Krysko O; Vedunova MV; Krysko DV
    Methods Cell Biol; 2024; 183():203-264. PubMed ID: 38548413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
    Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
    Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.